Publicaciones en colaboración con investigadores/as de University of California, San Diego (74)

2024

  1. Moderators of Loneliness Trajectories in People with Systemic Sclerosis During the COVID-19 Pandemic: A SPIN COVID-19 Cohort Longitudinal Study

    International Journal of Behavioral Medicine

2023

  1. A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: Application to BRCA1 and BRCA2

    Human Mutation, Vol. 2023

  2. A second update on mapping the human genetic architecture of COVID-19

    Nature

  3. An integrated model of psychosocial correlates of insomnia severity in family caregivers of people with dementia

    Aging and Mental Health

  4. Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD

    Journal of the American Society of Nephrology : JASN, Vol. 34, Núm. 6, pp. 955-968

  5. Efficient multi-fidelity computation of blood coagulation under flow

    PLoS Computational Biology, Vol. 19, Núm. 10

  6. Pulmonary vein flow split effects in patient-specific simulations of left atrial flow

    Computers in Biology and Medicine, Vol. 163

  7. Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors

    Journal of the National Cancer Institute, Vol. 115, Núm. 12, pp. 1605-1615

2022

  1. Acute Heart Failure in the 2021 ESC Heart Failure Guidelines: A scientific statement from the Association for Acute CardioVascular Care (ACVC) of the European Society of Cardiology

    European Heart Journal: Acute Cardiovascular Care, Vol. 11, Núm. 2, pp. 173-185

  2. Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study

    Journal of Clinical Microbiology, Vol. 60, Núm. 1

  3. B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)

    Frontiers in Oncology, Vol. 12

  4. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

    Blood, Vol. 140, Núm. 26, pp. 2773-2787

  5. COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA

    Blood, Vol. 139, Núm. 10, pp. 1588-1592

  6. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

    Breast Cancer Research, Vol. 24, Núm. 1

  7. Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)

    Journal of Allergy and Clinical Immunology, Vol. 149, Núm. 2, pp. 659-670

  8. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

    The Lancet Gastroenterology and Hepatology, Vol. 7, Núm. 2, pp. 128-140

  9. Non-Newtonian blood rheology impacts left atrial stasis in patient-specific simulations

    International Journal for Numerical Methods in Biomedical Engineering, Vol. 38, Núm. 6

  10. Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report

    American Journal of Hematology

  11. Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study

    British Journal of Sports Medicine, Vol. 56, Núm. 20, pp. 1157-1170

  12. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology

    Clinical Microbiology and Infection, Vol. 28, Núm. 4, pp. 580-587